Premium
Implementation of a pharmacogenomics consult service to support the INGENIOUS trial
Author(s) -
Eadon MT,
Desta Z,
Levy KD,
Decker BS,
Pierson RC,
Pratt VM,
Callaghan JT,
Rosenman MB,
Carpenter JS,
Holmes AM,
McDonald CA,
Benson EA,
Patil AS,
Vuppalanchi R,
Gufford BT,
Dave N,
Robarge JD,
Hyder MA,
Haas DM,
Kreutz RP,
Dexter PR,
Skaar TC,
Flockhart DA
Publication year - 2016
Publication title -
clinical pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.941
H-Index - 188
eISSN - 1532-6535
pISSN - 0009-9236
DOI - 10.1002/cpt.347
Subject(s) - pharmacogenomics , credentialing , adjudication , service (business) , medicine , clinical trial , business , nursing , pharmacology , political science , marketing , law
Hospital systems increasingly utilize pharmacogenomic testing to inform clinical prescribing. Successful implementation efforts have been modeled at many academic centers. In contrast, this report provides insights into the formation of a pharmacogenomics consultation service at a safety‐net hospital, which predominantly serves low‐income, uninsured, and vulnerable populations. The report describes the INdiana GENomics Implementation: an Opportunity for the UnderServed (INGENIOUS) trial and addresses concerns of adjudication, credentialing, and funding.